Robotic surgery saw 8.4-fold increase from 2012 to 2018

Robotic surgery saw 8.4-fold increase from 2012 to 2018

January 14, 2020 Robotic surgery saw 8.4-fold increase from 2012 to 2018 (HealthDay)—Hospitals that launch robotic surgery programs have a broad and immediate increase in the use of robotic surgery, accompanied by a decrease in traditional laparoscopic minimally invasive surgery, according to a study published online Jan. 10 in JAMA Network Open . Kyle H. Sheetz, M.D., from University of Michigan in Ann Arbor, and colleagues used clinical registry data from Michigan (Jan. 1, 2012, through June 30, 2018) to assess trends in the use of robotic surgery for common procedures for which traditional laparoscopic minimally invasive surgery was already considered a safe and effective approach. The researchers identified 169,404 patients (mean age, 55.4 years; 53.5 percent women) at 73 hospitals. The use of robotic surgery increased 8.4-fold (1.8 percent in 2012 to 15.1 percent in 2018), with the magnitude even greater for some procedures (inguinal hernia repair, 0.7 to 28.8 percent). In the first four years after hospitals began performing robotic surgery, its use increased 8.8 percent. This increase was associated with a decrease in laparoscopic surgery (53.2 to 51.3 percent), which had previously been increasing 1.3 percent per year before adoption of robotic surgery. "These findings highlight a need to continually monitor the adoption of robotic surgery to ensure that enthusiasm for new technology does not outpace the evidence needed to use it in the most effective clinical contexts," the authors write. One author disclosed financial ties to ArborMetrix. Explore further



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More